Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication.
Co-infection of human immunodeficiency virus (HIV) with malaria is one of the pandemic problems in Africa and parts of Asia. Here we investigated the impact of pyrimethamine (PYR) and two other clinical anti-malarial drugs (chloroquine [CQ] or artemisinin [ART]) on HIV-1 replication. Peripheral blood mononuclear cells (PBMCs) or MT-2 cells were infected with HIV(NL4.3) strain and treated with different concentrations of the anti-malarial drugs. HIV-1 replication was measured using p24 ELISA. We show that 10 μM CQ and ART inhibited HIV-1 replication by 76% and 60% in PBMCs, respectively, but not in MT-2 cells. In contrast, 10 μM PYR enhanced HIV-1 replication in MT-2 cells by >10-fold. A series of molecular mechanism studies revealed that PYR increased intracellular HIV gag proteins without affecting the promoter or the reverse transcriptase activity. The effect of PYR was independent of HTLV-1 produced by MT-2 cells. Of interest, PYR treatment led to S-phase accumulation and increased AZT and d4T antiviral activity by ∼ 4-fold. Taken together, we show that PYR significantly enhances HIV-1 replication by affecting the cellular machinery. Our results could be relevant for the management of malaria and HIV particularly in regions where HIV-1 and malaria epidemics overlap.
Oguariri
Raphael M
RM
Laboratory of Human Retrovirology, Science Applications International Corporation-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD 21702, USA. oguaririr@mail.nih.gov
Adelsberger
Joseph W
JW
Baseler
Michael W
MW
Imamichi
Tomozumi
T
D000962:Antimalarials / Q000494:pharmacology*; D000998:Antiviral Agents / Q000494:pharmacology*; D037621:Artemisinins / Q000494:pharmacology; D002478:Cells, Cultured; D002738:Chloroquine / Q000494:pharmacology; D004797:Enzyme-Linked Immunosorbent Assay; D016655:HIV Core Protein p24 / Q000032:analysis; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000821:virology; D008214:Lymphocytes / Q000821:virology; D011739:Pyrimethamine / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects*
D000962:Antimalarials; D000998:Antiviral Agents; D037621:Artemisinins; D016655:HIV Core Protein p24; D002738:Chloroquine; C031327:artemisinin; D011739:Pyrimethamine
Curr Pharm Des. 2007;13(6):609-39
17346178
Science. 1987 Nov 6;238(4828):800-2
3313729
AIDS Rev. 2007 Apr-Jun;9(2):88-98
17694676
J Virol Methods. 1987 Jun;16(3):171-85
2821048
Parasitol Res. 2003 Aug;90(6):467-72
12802682
Cell Biol Toxicol. 1991 Oct;7(4):347-56
1794109
J Biol Chem. 1988 Apr 25;263(12):5870-5
3258602
J Virol. 2003 Jan;77(2):1011-20
12502817
Science. 1985 Aug 9;229(4713):563-6
2992081
Antiviral Res. 2005 Nov;68(2):75-83
16122816
Med Microbiol Immunol. 1984;173(3):127-40
6094998
AIDS. 2007 Mar 30;21(6):763-5
17413699
Lancet. 2003 Sep 27;362(9389):1008-9
14522527
Trends Parasitol. 2007 Oct;23(10):465-7
17822960
Clin Infect Dis. 2007 Nov 1;45(9):1214-20
17918087
Blood. 2007 Mar 1;109(5):1841-9
17068156
Trends Parasitol. 2008 Jun;24(6):264-71
18456554
Eur J Pediatr. 2006 Jan;165(1):19-25
16133245
J Biol Chem. 2007 Feb 9;282(6):3594-604
17150965
Biochem Pharmacol. 1992 Apr 15;43(8):1805-9
1575774
J Virol. 1982 Jan;41(1):183-91
6283112
Am J Med. 1988 Jan;84(1):94-100
3337134
Curr Infect Dis Rep. 2007 Jan;9(1):47-54
17254504
N Engl J Med. 1993 Apr 22;328(16):1173-82
8455685
Antimicrob Agents Chemother. 1996 Jul;40(7):1623-7
8807051
J Biol Chem. 1966 Oct 25;241(20):4802-9
5926184
Ann Neurol. 1994 Nov;36(5):787-90
7979225
Science. 2007 Mar 30;315(5820):1791; author reply 1791
17395812
Antimicrob Agents Chemother. 1992 May;36(5):1040-8
1510391
Infection. 1996 Jul-Aug;24(4):324-7
8875286
J Virol. 2006 Jun;80(12):6136-45
16731952
Am J Med. 1987 May;82(5):907-14
3578360
Science. 2006 Dec 8;314(5805):1603-6
17158329
Ann Intern Med. 1992 Jan 1;116(1):33-43
1727093
Cancer Chemother Pharmacol. 2000;46(6):477-87
11138461
J Virol. 1986 Aug;59(2):284-91
3016298
Curr Pharm Des. 2006;12(15):1827-41
16724950
Virology. 1981 Apr 15;110(1):202-7
7210505
Infect Immun. 2001 Dec;69(12):7603-9
11705939
J Anal Toxicol. 1993 Jul-Aug;17(4):248-50
8371558
Int J Parasitol. 2002 Dec 4;32(13):1655-60
12435450
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2365-8
2784570
Clin Infect Dis. 2007 May 1;44(9):1229-34
17407044
J Infect Dis. 1989 Sep;160(3):557-8
2760509
Cancer Res. 1979 Sep;39(9):3531-9
476679
AIDS. 2006 Oct 24;20(16):1993-2004
17053345
Mol Cell Biochem. 1994 Nov 9;140(1):1-22
7877593
AIDS Rev. 2007 Jul-Sep;9(3):140-9
17982939
J Biol Chem. 2006 May 12;281(19):13388-13395
16497663
Science. 1989 Dec 1;246(4934):1155-8
2479983
Clin Immunol. 2000 Dec;97(3):241-7
11112363
Lancet. 2005 Jan 15-21;365(9455):196-7
15652587